SPONSOR
HK inno.N Corporation
Total Trials
2
Recruiting
2
Phases
Phase 2
HK inno.N Corporation is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Mild to Moderate Atopic Dermatitis, Adjuvant Chemotherapy.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — HK inno.N Corporation
How many clinical trials has HK inno.N Corporation sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by HK inno.N Corporation, of which 2 are actively recruiting participants. These trials cover conditions including Mild to Moderate Atopic Dermatitis, Adjuvant Chemotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does HK inno.N Corporation research focus on?
HK inno.N Corporation clinical trials span Mild to Moderate Atopic Dermatitis, Adjuvant Chemotherapy. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a HK inno.N Corporation clinical trial?
To participate in a HK inno.N Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all HK inno.N Corporation trials with current recruitment status updated daily.
Clinical Trials by HK inno.N Corporation
NCT07073677 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
Mild to Moderate Atopic Dermatitis
NCT06389552
Recruiting
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
Adjuvant Chemotherapy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology